Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
12/2008
12/31/2008CN101333181A Novel crystalline forms of perindopril erbumine
12/31/2008CN101332295A Enteric-coated glucosinolates and beta-thioglucosidases
12/31/2008CN101332294A Use of human-source adiponcetin globular segment for medicine for treating diabetes and ischemic heart disease
12/31/2008CN101332263A Preparation method of traditional Chinese medicine for reducing platelet aggregation rate of coronary heart disease
12/31/2008CN101332246A Traditional Chinese medicine preparation for treating coronary heart disease and angina
12/31/2008CN101332242A Decoction for treating hemorrhoidal hemorrhage
12/31/2008CN101332241A Medicinal wine for treating apoplectic sequela and hemiparalysis
12/31/2008CN101332233A Panax ginseng storax mill capsules
12/31/2008CN101332232A Use of traditional Chinese medicine composition in preparing medicine for treating coronary heart disease, angina
12/31/2008CN101332231A Medicine for treating heart failure
12/31/2008CN101332230A Prunella plant extract, preparation method and use thereof
12/31/2008CN101332229A Prunella plant extract, preparation method and use thereof
12/31/2008CN101332227A Preparation method of Clary injection
12/31/2008CN101332194A Compound atenolol tablet and preparation method thereof
12/31/2008CN101332191A Stable perindopril tert-butylamine salt tablets and preparation method thereof
12/31/2008CN101332182A Emulsion containing alprostadil for intravenous transfusion and preparation method thereof
12/31/2008CN101332176A Medicine composition for injecting cinnarizine lipid microsphere and preparation method thereof
12/31/2008CN101332036A Natural plant health preserving pillow
12/31/2008CN101331964A Rosa multiflora beverage and preparation method thereof
12/31/2008CN101331946A 一种葛根饮料 One kind of beverage Pueraria
12/31/2008CN100447244C BAFF receptor (BCMA), immunoregulatory agent
12/31/2008CN100447154C Use of HMG fragments as anti-inflammatory agents
12/31/2008CN100447148C Cape jasmine extract , its preparing process and application
12/31/2008CN100447143C Compounds and compositions as inhibitors of receptor tyrosine kinase activity
12/31/2008CN100447142C Imidazo[1, 5a]pyridine derivatives and methods for treating aldosterone mediated diseases
12/31/2008CN100447141C Hetero-bicyclic crf antagonists
12/31/2008CN100446810C Non-neurotoxic plasminogen activating factors for treating stroke
12/31/2008CN100446799C Medicine for treating cardiac and cerebral vascular diseases and its preparation
12/31/2008CN100446780C Method for preparing injection preparation of freeze drying powder of Xuesaitong
12/31/2008CN100446779C Method for preparing acanthopanax senticousus extracting liquid/extraction
12/31/2008CN100446778C Method of preparing solution / substance extracted from ginkgo leaves
12/31/2008CN100446771C New medicinal composition
12/31/2008CN100446762C (-)-epigallocatechin gallate solid dispersion and its prepn and application
12/31/2008CN100446759C Gastrodine tablets disintegrating in oral cavity and process for producing same
12/31/2008CA2696961A1 Treatment of heart failure in non-human animal mammals by an aldosterone antagonist
12/31/2008CA2691415A1 Tpp ii inhibitors for use in the treatment of autoimmune and inflammatory diseases and transplant rejection
12/31/2008CA2691003A1 Methods of treating serotonin-mediated diseases and disorders
12/31/2008CA2690371A1 Peptide having hypotensive activity
12/31/2008CA2690335A1 Benzazepine derivatives useful as vasopressin antagonists
12/31/2008CA2689299A1 Synergistic combination of anthranilamide pyridinureas and benzamide derivatives
12/31/2008CA2689109A1 N5-(2-ethoxyethyl)-n3-(2-pyridinyl) -3,5-piperidinedicarboxamide derivatives for use as renin inhibitors
12/31/2008CA2687557A1 Polyfunctional fullerene c60 amino acid derivatives
12/31/2008CA2687165A1 Use of nitric oxide-releasing statins in the treatment of pulmonary arterial hypertension
12/30/2008US7470719 Metastable benzoxepne derivatives which can be used in the treatment of dyslipidaemia a therosclerosis and diabetes, pharmaceutical compositions comprising them and processes for the preparation thereof
12/30/2008US7470710 Such as 2-Benzofuranylmethyl-1-((5-(4-fluorophenyl)-2-methyl-thiazolyl) carbonyl)piperidine; obesity, type 2 diabetes, sleep disorders; strokes, blocking emetic response
12/30/2008US7470698 Adenosine A3 receptor modulators
12/30/2008US7470694 Treating atherosclerosis by administering 1-(N-(2-(diethylamino)ethyl)-N-(4-(4-trifluoromethylphenyl)benzyl)aminocarbonylmethyl)-2-(4-fluorobenzyl)thio-5,6-trimethylenepyrimidin-4-one or a salt; coadministering an anticholesterol agent; inhibitor of platlet activating factor acetylhydrolase
12/30/2008US7470688 Phthalazinone derivatives
12/30/2008US7470687 Aryl oximes
12/30/2008US7470686 e.g. 1,3-benzothiazol-2-yl (2-chloral -4-pyrimidinyl)acetonitrile; Jun N -terminal kinase inhibitor; anticarcinogenic agent; neuronal disorders, autoimmune diseases, cardiovascular disordres
12/30/2008US7470678 Diphenylazetidinone derivatives for treating disorders of the lipid metabolism
12/30/2008CA2412560C Pyrrolo[2,3-d]pyrimidine compounds as immunosuppressive agents
12/30/2008CA2412452C Process for the preparation of substituted octanoyl amides
12/30/2008CA2391497C Use of 5ht3 agonists for relaxing the fundus
12/30/2008CA2368767C Protease resistant flint analogs
12/30/2008CA2351703C Novel 4-dedimethylaminotetracycline derivatives
12/30/2008CA2349195C New manufacturing process
12/30/2008CA2312098C A process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs
12/30/2008CA2285389C Use of cytoskeletal inhibitors for the prevention of restenosis
12/30/2008CA2250295C Water soluble paclitaxel prodrugs
12/30/2008CA2245587C Novel benzo-1,3-dioxolyl- and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists
12/30/2008CA2212207C Use of isoxazole and crotonamide derivatives for the modulation of apoptosis
12/30/2008CA2186364C Substituted azetidinone compounds useful as hypocholesterolemic agents
12/30/2008CA2162924C New peptide antagonists at glutamate and nmda receptors
12/25/2008US20080319551 Thioester-ester-amide copolymers
12/25/2008US20080319198 N-benzyl-N-{2-[7-(4-cyanobenzyl)-9-oxa-3,7-diazabicyclo[3.3.1]non-3-yl]ethyl}methane-sulfonamide; trial and ventricular arrhythmias; pharmacokinetics; electrophysiological activity; lowering daily clinical dose, lengthening duration of action; side effect reduction
12/25/2008US20080319178 Chimera humanized vascular endothelial growth factor
12/25/2008US20080319174 Chimera humanized vascular endothelial growth factor
12/25/2008US20080319165 Nucleic acid molecule comprising a nucleic acid sequence coding for a chemokine, a neuropeptide precursor, or at least one neuropeptide
12/25/2008US20080319051 Liquiritigenin and derivatives as selective estrogen receptor beta agonists
12/25/2008US20080319046 Substituted sulfonamide-indoles
12/25/2008US20080319044 Compounds and Methods of Use Thereof
12/25/2008US20080319040 N-Acylic Aminoacid Derivatives, Method For The Production Thereof, Pharmacological Composition And The Use In The Form Anti-Allergic, Anti-Inflammatory And Hypolipidemic Agents
12/25/2008US20080319036 administering to overweight subject a pharmaceutical composition comprising a sustained release formulation of zonisamide or a pharmaceutically acceptable salt thereof, either alone or in combination with bupropion or other compound that enhances the activity of norepinephrine and/or dopamine via uptake
12/25/2008US20080319027 Composition and Method for Treating Fibrotic Diseases
12/25/2008US20080319026 Substituted n-aryl pyridinones
12/25/2008US20080319022 2-Pyridyl substituted imidazoles as ALK5 and/or ALK4 inhibitors
12/25/2008US20080319021 Inhibition Of Phosphoinositide 3-Kinase Beta
12/25/2008US20080319017 Non-Anilinic Derivatives of Isothiazol-3(2H)-Thione 1,1-Dioxides As Liver X Receptor Modulators
12/25/2008US20080319013 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazole-2-ones and, 4-(substituted cycloalkylmethyl) imidazole-2-ones and related compounds
12/25/2008US20080319004 Deuterium-enriched clopidogrel
12/25/2008US20080319002 Xanthine Derivatives a Useful as Muscarinic Receptor Antagonists
12/25/2008US20080318981 Novel Compounds 480
12/25/2008US20080318980 USE OF 7-(PYRIMIDIN-4 YL)-IMIDAZO[1,2-a]PYRIMIDIN-5(1H)-ONES AS GSK-3BETA INHIBITORS
12/25/2008US20080318973 Urotensin II receptor antagonists
12/25/2008US20080318969 Anti-anginal compounds
12/25/2008US20080318961 Drugs comprising chymase inhibitors and ACE inhibitors as effective ingredients
12/25/2008US20080318960 PAR2-modulating compounds and their use
12/25/2008US20080318958 New utilities of tricyclic compounds
12/25/2008US20080318951 Dual-acting benzoimidazole antihypertensive agents
12/25/2008US20080318944 N-aroyl cyclic amine derivatives as orexin receptor antagonists
12/25/2008US20080318932 Sodium Channel Blocker Compositions and the Use Thereof
12/25/2008US20080318909 Use Of Linoleic Compounds Against Heart Failure
12/25/2008US20080318893 Blockade of Calcium Channels
12/25/2008US20080318866 Medicament for treatment of non-insulin dependent diabetes mellitus, hypertension and/or metabolic syndrome
12/25/2008US20080318863 Ischemia therapeutic agent
12/25/2008US20080318860 High Activity Growth Factor Mutants
12/25/2008US20080318857 Compositions and Methods for the Intracellular Disruption of Vegf and Vegfr-2 By Intraceptors
12/25/2008US20080318842 Cyclic Isodityrosine Derivatives
12/25/2008US20080318338 Drug screening using a high affinity form of Heat Shock Protein-90 (HSP90) that has a 17-allylamino-geldanamycin (17-AAG) binding affinity
1 ... 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 ... 1595